BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35158780)

  • 21. Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy.
    Menges M; Müller M; Zeitz M
    Am J Gastroenterol; 2001 Feb; 96(2):331-7. PubMed ID: 11232672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pleiotropic analysis of cancer risk loci on esophageal adenocarcinoma risk.
    Lee E; Stram DO; Ek WE; Onstad LE; MacGregor S; Gharahkhani P; Ye W; Lagergren J; Shaheen NJ; Murray LJ; Hardie LJ; Gammon MD; Chow WH; Risch HA; Corley DA; Levine DM; Whiteman DC; Bernstein L; Bird NC; Vaughan TL; Wu AH
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1801-3. PubMed ID: 26364162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett's esophagus, and high-grade dysplasia/esophageal adenocarcinoma.
    Buas MF; Gu H; Djukovic D; Zhu J; Onstad L; Reid BJ; Raftery D; Vaughan TL
    Metabolomics; 2017 Mar; 13(3):. PubMed ID: 28190989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is Barrett's esophagus characterized by more pronounced acid reflux than severe esophagitis?
    Coenraad M; Masclee AA; Straathof JW; Ganesh S; Griffioen G; Lamers CB
    Am J Gastroenterol; 1998 Jul; 93(7):1068-72. PubMed ID: 9672332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux.
    Sarr MG; Hamilton SR; Marrone GC; Cameron JL
    Am J Surg; 1985 Jan; 149(1):187-93. PubMed ID: 3966636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional foregut abnormalities in Barrett's esophagus.
    Stein HJ; Hoeft S; DeMeester TR
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):107-11. PubMed ID: 8419690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in activity and phosphorylation of MAPK enzymes in esophageal squamous cells of GERD patients with and without Barrett's esophagus.
    Zhang HY; Zhang X; Chen X; Thomas D; Hormi-Carver K; Elder F; Spechler SJ; Souza RF
    Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G470-8. PubMed ID: 18617556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.
    Csendes A; Smok G; Cerda G; Burdiles P; Mazza D; Csendes P
    Dis Esophagus; 1997 Jan; 10(1):38-42. PubMed ID: 9079272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma.
    Romero Y; Cameron AJ; Locke GR; Schaid DJ; Slezak JM; Branch CD; Melton LJ
    Gastroenterology; 1997 Nov; 113(5):1449-56. PubMed ID: 9352846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux.
    Ek WE; Levine DM; D'Amato M; Pedersen NL; Magnusson PK; Bresso F; Onstad LE; Schmidt PT; Törnblom H; Nordenstedt H; Romero Y; ; Chow WH; Murray LJ; Gammon MD; Liu G; Bernstein L; Casson AG; Risch HA; Shaheen NJ; Bird NC; Reid BJ; Corley DA; Hardie LJ; Ye W; Wu AH; Zucchelli M; Spector TD; Hysi P; Vaughan TL; Whiteman DC; MacGregor S;
    J Natl Cancer Inst; 2013 Nov; 105(22):1711-8. PubMed ID: 24168968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Esophageal acid sensitivity in Barrett's esophagus.
    Johnson DA; Winters C; Spurling TJ; Chobanian SJ; Cattau EL
    J Clin Gastroenterol; 1987 Feb; 9(1):23-7. PubMed ID: 3559107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detailed esophageal function and morphological analysis shows high prevalence of gastroesophageal reflux disease and Barrett's esophagus in patients with cervical inlet patch.
    Rosztóczy A; Izbéki F; Németh IB; Dulic S; Vadászi K; Róka R; Gecse K; Gyökeres T; Lázár G; Tiszlavicz L; Wittmann T
    Dis Esophagus; 2012 Aug; 25(6):498-504. PubMed ID: 22107367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Anderson LA; Cantwell MM; Watson RG; Johnston BT; Murphy SJ; Ferguson HR; McGuigan J; Comber H; Reynolds JV; Murray LJ
    Gastroenterology; 2009 Mar; 136(3):799-805. PubMed ID: 19162028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Esophageal atresia and transitional care--step 1: a systematic review and meta-analysis of the literature to define the prevalence of chronic long-term problems.
    Connor MJ; Springford LR; Kapetanakis VV; Giuliani S
    Am J Surg; 2015 Apr; 209(4):747-59. PubMed ID: 25605033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality associated with Barrett's esophagus and gastroesophageal reflux disease diagnoses-a population-based cohort study.
    Solaymani-Dodaran M; Logan RF; West J; Card T
    Am J Gastroenterol; 2005 Dec; 100(12):2616-21. PubMed ID: 16393209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Esophageal atresia: metaplasia, Barrett.
    Schneider A; Michaud L; Gottrand F
    Dis Esophagus; 2013; 26(4):425-7. PubMed ID: 23679037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease.
    Winters C; Spurling TJ; Chobanian SJ; Curtis DJ; Esposito RL; Hacker JF; Johnson DA; Cruess DF; Cotelingam JD; Gurney MS
    Gastroenterology; 1987 Jan; 92(1):118-24. PubMed ID: 3781178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is the real impairment on esophageal motility in patients with gastroesophageal reflux disease?
    Falcão A; Nasi A; Brandão J; Sallum R; Cecconello I
    Arq Gastroenterol; 2013 Apr; 50(2):111-6. PubMed ID: 23903620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of bacterial biota in the distal esophagus of Japanese patients with reflux esophagitis and Barrett's esophagus.
    Liu N; Ando T; Ishiguro K; Maeda O; Watanabe O; Funasaka K; Nakamura M; Miyahara R; Ohmiya N; Goto H
    BMC Infect Dis; 2013 Mar; 13():130. PubMed ID: 23496929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.